Article

BD Medical–Ophthalmic Systems introduces new safety knives

Waltham, MA-BD Medical–Ophthalmic Systems, a unit of BD (Becton, Dickinson and Co.), has launched a new line of safety knives (BD Atomic Edge).

Waltham, MA-BD Medical–Ophthalmic Systems, a unit of BD (Becton, Dickinson and Co.), has launched a new line of safety knives (BD Atomic Edge).

The blades, made of single-crystal silicon, are developed through the technology and processes used in the fabrication of semiconductors.

“Silicon and diamond have the same diamond cubic crystalline structure,” said Doug Lawrence, vice president and general manager, BD Medical–Ophthalmic Systems. “Using semiconductor manufacturing technology, [the company] offers an alternative to a diamond blade at the price of a single-use blade.”

To reduce the risk of sharps injuries associated with ophthalmic surgery, each blade is mounted in a safety handle with a retractable shield.
 
“In this era of concerns about blood-borne diseases such as HIV/AIDS, hepatitis C, and variant Creutzfeldt-Jakob disease, reducing the risk of accidental injury or contamination with patient blood is of great interest to all health-care workers,” said Randall J. Olson, MD, director, Moran Eye Center, University of Utah School of Medicine, Salt Lake City. “Shielded safety knives can go a long way to protecting health-care professionals during surgery.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.